131 related articles for article (PubMed ID: 8169097)
1. Dose requirements for a nonionic contrast agent for spiral computed tomography of the liver in rabbits.
Bluemke DA; Fishman EK; Anderson JH
Invest Radiol; 1994 Feb; 29(2):195-200. PubMed ID: 8169097
[TBL] [Abstract][Full Text] [Related]
2. Effect of contrast concentration on abdominal enhancement in the rabbit: spiral computed tomography evaluation.
Bluemke DA; Fishman EK; Anderson JH
Acad Radiol; 1995 Mar; 2(3):226-31. PubMed ID: 9419553
[TBL] [Abstract][Full Text] [Related]
3. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
[TBL] [Abstract][Full Text] [Related]
4. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times.
Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N
AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963
[TBL] [Abstract][Full Text] [Related]
5. Hepatic spiral CT: reduction of dose of intravenous contrast material.
Brink JA; Heiken JP; Forman HP; Sagel SS; Molina PL; Brown PC
Radiology; 1995 Oct; 197(1):83-8. PubMed ID: 7568859
[TBL] [Abstract][Full Text] [Related]
6. Hepatic spiral CT in children: scan delay time-enhancement analysis.
Luker GD; Siegel MJ; Bradley DA; Baty JD
Pediatr Radiol; 1996; 26(5):337-40. PubMed ID: 8657463
[TBL] [Abstract][Full Text] [Related]
7. An optimal contrast dose indicator for the determination of hepatic enhancement in abdominal multidetector computed tomography: comparison of patient attenuation indicator with total body weight and body mass index.
Li J; Udayasankar UK; Tang X; Carew J; Toth TL; Small WC
J Comput Assist Tomogr; 2010; 34(6):874-8. PubMed ID: 21084903
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement.
Small WC; Nelson RC; Bernardino ME; Brummer LT
AJR Am J Roentgenol; 1994 Jul; 163(1):87-92. PubMed ID: 8010255
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits.
Krause W; Handreke K; Schuhmann-Giampieri G; Rupp K
Invest Radiol; 2002 May; 37(5):241-7. PubMed ID: 11979149
[TBL] [Abstract][Full Text] [Related]
10. Application of pharmacokinetics to computed tomography: injection rates and schemes: mono-, bi-, or multiphasic?
Krause W
Invest Radiol; 1996 Feb; 31(2):91-100. PubMed ID: 8750444
[TBL] [Abstract][Full Text] [Related]
11. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
[TBL] [Abstract][Full Text] [Related]
12. Contrast material injection for hepatic helical computed tomography. Comparative study of five protocols.
Hoeffel C; Legmann P; Girardot C; Bunouf P; Mezzi K; Bonnin A
Invest Radiol; 1996 Aug; 31(8):467-71. PubMed ID: 8854192
[TBL] [Abstract][Full Text] [Related]
13. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
[TBL] [Abstract][Full Text] [Related]
14. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion.
Blomley MJ; Coulden R; Bufkin C; Lipton MJ; Dawson P
Invest Radiol; 1993 Nov; 28 Suppl 5():S72-7; discussion S78. PubMed ID: 8282508
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and evaluation of ioxilan carbonate particles for computed tomography contrast enhancement of liver.
Li C; Kan Z; Yang DJ; Kuang LR; Liu CW; Wright KC; Wallace S
Invest Radiol; 1994 Nov; 29(11):1006-13. PubMed ID: 7890508
[TBL] [Abstract][Full Text] [Related]
16. Hepatic imaging with iodinated nanoparticles: a comparison with iohexol in rabbits.
Gazelle GS; Wolf GL; McIntire GL; Bacon ER; Na G; Halpern EF; Toner JL
Acad Radiol; 1995 Aug; 2(8):700-4. PubMed ID: 9419627
[TBL] [Abstract][Full Text] [Related]
17. Optimal delay time for the hepatic parenchymal enhancement at the multidetector CT examination.
Chung YE; Kim KW; Kim JH; Lim JS; Oh YT; Chung JJ; Kim MJ
J Comput Assist Tomogr; 2006; 30(2):182-8. PubMed ID: 16628029
[TBL] [Abstract][Full Text] [Related]
18. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
[TBL] [Abstract][Full Text] [Related]
19. Effect of injection rate of contrast medium on pancreatic and hepatic helical CT.
Tublin ME; Tessler FN; Cheng SL; Peters TL; McGovern PC
Radiology; 1999 Jan; 210(1):97-101. PubMed ID: 9885593
[TBL] [Abstract][Full Text] [Related]
20. Individual Optimization of Contrast Media Injection Protocol at Hepatic Dynamic Computed Tomography Using Patient-Specific Contrast Enhancement Optimizer.
Matsumoto Y; Higaki T; Arataki K; Masuda T; Sato T; Fukumoto W; Nakamura Y; Tatsugami F; Awai K
J Comput Assist Tomogr; 2020; 44(2):230-235. PubMed ID: 32195801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
